2022

Publikationer udgivet 2022 – Klinisk Fysiologi og Nuklearmedicin, pr. 22.03.23 
  1. Andersen JD, Fabrin K, Petersen A, Zacho HD. 18F-FDG PET/CT in a Case of Urothelial Carcinoma in the Urachus Presenting as Colon Cancer. Diagnostics. 2022;12(1):31. doi: 10.3390/diagnostics12010031 
     
  2. Danielsen MB, Jødal L, Riis J, Karmisholt JS, Valdórsson Ó, Jørgensen MG et al. Absorption rate of subcutaneously infused fluid in ill multimorbid older patients. PLOS ONE. 2022 okt.;17(10):e0275783. e0275783. doi: 10.1371/journal.pone.0275783 
     
  3. Tram L, Kubik M, Kvist Jensen K, Almasi CE. Brown tumor mimicking metastases-the late manifestation of hyperparathyroidism. Acta Radiologica Open. 2022 sep.;11(9):1-3. doi: 10.1177/20584601221128415 
     
  4. Alberts I, Mingels C, Zacho HD, Lanz S, Schöder H, Rominger A et al. Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2022 okt.;49(12):4252–4261. Epub 2021 nov. 13. doi: 10.1007/s00259-021-05620-9 
     
  5. Bebbington N, Zacho HD, Holdgaard PC. Dose Savings Associated with Personalised CT Scan Range in F-18 Sodium-Fluoride PET-CT. European Journal of Nuclear Medicine and Molecular Imaging. 2022 sep. 22;49(Suppl. 1):S347. 
     
  6. Jødal L, Brignone JI, Ladefoged PC, Lund L, Andersen TB. GFR determination in pigs based on late samples only. European Journal of Nuclear Medicine and Molecular Imaging. 2022 sep. 22;49(Suppl. 1):S451. 
     
  7. Gossili F, Carlé A, Andersen TB, Zacho HD. Giant Parathyroid Tumor: Parathyroid Adenoma versus Parathyroid Carcinoma. Case reports in endocrinology. 2022 okt. 26;2022:7712097. doi: 10.1155/2022/7712097 
     
  8. Lange MB, Petersen LJ, Lausen M, Bruun NH, Nielsen MB, Zacho HD. Influence of Prior Imaging Information on Diagnostic Accuracy for Focal Skeletal Processes-A Retrospective Analysis of the Consistency between Biopsy-Verified Imaging Diagnoses. Diagnostics. 2022 jul. 17;12(7):1735. doi: 10.3390/diagnostics12071735 
     
  9. Beykan S, Tran-Gia J, Borup Jensen S, Lassmann M. Is a single late SPECT/CT based kidney 177Lu-dosimetry superior to hybrid dosimetry with sequential multiple time-point whole-body planar scans in combination with an early SPECT/CT? Physica Medica. 2022 aug.;100:39-50. Epub 2022 jun. 17. doi: 10.1016/j.ejmp.2022.06.002 
     
  10. Jensen SB, Meyer LS, Nielsen NS, Nielsen SS. Issues with the European Pharmacopoeia Quality Control Method for 99mTc-Labelled Macroaggregated Albumin. Molecules. 2022 jul.;27(13):3997. doi: 10.3390/molecules27133997 
     
  11. Bebbington NA, Zacho HD, Holdgaard PC. Lesion detection in 18F-sodium fluoride bone imaging: a comparison of attenuation-corrected versus nonattenuation-corrected PET reconstructions from modern PET-CT systems. Nuclear Medicine Communications. 2022 jan. 1;43(1):78-85. doi: 10.1097/MNM.0000000000001487 
     
  12. Afzelius P, Morsing MK, Nielsen OL, Alstrup AKO, Jensen SB, Jødal L. Lymph Nodes Draining Infections Investigated by PET and Immunohistochemistry in a Juvenile Porcine Model. Molecules. 2022 apr. 27;27(9):2792. doi: 10.3390/molecules27092792 
     
  13. Jakobsen SS, Frøkjær JB, Fisker RV, Kristensen SR, Thorlacius-Ussing O, Larsen AC. Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients. Thrombosis Research. 2022 maj;213(Suppl. 2):S11-S12. doi: 10.1016/S0049-3848(22)00190-6 
     
  14. Bentestuen M, Al-Oybadi N, Zacho HD. Non-malignant FAPI-avid PET/CT Findings: A Review. European Journal of Nuclear Medicine and Molecular Imaging. 2022 sep. 22;49(Suppl. 1):S525. 
     
  15. Zacho HD, Ravn S, Ejlersen JA, Fledelius J, Dolliner P, Nygaard ST et al. Observer experience and accuracy of 18F-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer. Nuclear Medicine Communications. 2022 jun.;43(6):680-686. Epub 2022 apr. 1. doi: 10.1097/MNM.0000000000001550 
     
  16. Bentestuen M, Gossili F, Almasi CE, Zacho HD. Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature. Cancer Imaging. 2022 sep. 3;22(1):44. doi: 10.1186/s40644-022-00484-0 
     
  17. Zacho HD, Nalliah S, Petersen A, Petersen LJ. The clinical consequences of routine 68Ga-PSMA-11 PET/CT in patients with newly diagnosed prostate cancer, ISUP grade 5 and no metastases based on standard imaging - preliminary results. Scandinavian Journal of Urology. 2022;56(5-6):353-358. Epub 2022 sep. 8. doi: 10.1080/21681805.2022.2119272 
     
  18. Aleksyniene R, Iyer V, Bertelsen HC, Nilsson MF, Khalid V, Schønheyder HC et al. The Role of Nuclear Medicine Imaging with 18F-FDG PET/CT, Combined 111In-WBC/99mTc-Nanocoll, and 99mTc-HDP SPECT/CT in the Evaluation of Patients with Chronic Problems after TKA or THA in a Prospective Study. Diagnostics. 2022 mar. 10;12(3):681. doi: 10.3390/diagnostics12030681 
     
  19. Nalliah S, Zacho HD. The value of 68Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging. Nuclear Medicine Communications. 2022 okt. 1;43(10):1092-1098. Epub 2022 aug. 5. doi: 10.1097/MNM.0000000000001602 
     
  20. Mogensen AW, Petersen LJ, Torp-Pedersen C, Nørgaard M, Pank MT, Zacho HD. Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients: a nationwide cohort study. BMJ Open. 2022 jun. 15;12(6):e058898. doi: 10.1136/bmjopen-2021-058898 
     
  21. Mogensen AW, Petersen LJ, Torp-Pedersen C, Nørgaard M, Pank MT, Zacho HD. Use of 18F-NaF-PET in the Staging of Skeletal Metastases of Newly Diagnosed, High-Risk Prostate Cancer Patients - a Nationwide Cohort Study. European Journal of Nuclear Medicine and Molecular Imaging. 2022;49(Suppl. 1):S402. EPS-231. 
     
  22. Mogensen AW, Petersen LJ, Torp-Pedersen C, Nørgaard M, Pank MT, Zacho HD. Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients - a nationwide cohort study. European Urology. 2022;81(Suppl. 1):S1224. A0827 . doi: 10.1016/S0302-2838(22)00904-6 
     

Ovenstående rapport er sorteret efter: Titel